Nigeria will take centre stage in the global health arena as it prepares to host the 5th High-Level Ministerial Meeting on Antimicrobial Resistance (AMR) from June 28 to 30, 2026. Marking a historic first for Africa, the summit will convene representatives from more than 100 countries in Abuja to confront the escalating threat of drug-resistant infections.
The country’s President, Bola Tinubu will officially welcome high-level delegations, including leaders from Botswana and Ghana, to the landmark event themed “One Health: Advancing Global AMR Commitments through Local Action.” The gathering is expected to shift global momentum from policy pledges to concrete, country-level implementation.
Antimicrobial resistance often dubbed the “silent pandemic” is driven by the widespread misuse and overuse of antibiotics and other antimicrobial drugs across human health, agriculture, and the environment. The result is a dangerous loss of effectiveness in life-saving treatments, putting millions of lives at risk each year.
Dr Ayoade Alakija, Nigeria’s Ministerial Global Envoy on AMR, said the Abuja meeting will prioritise solutions and financing. “This is about moving from commitments to action. We must invest in prevention, surveillance, and systems that protect both people and ecosystems,” she noted, stressing that AMR requires coordinated responses beyond the health sector alone.
That broader approach is reflected in the summit’s design. Ministers of health will be joined by counterparts in agriculture, environment, and finance—highlighting the interconnected nature of AMR under the “One Health” framework.
Dr Jean Pierre Nyemazi of the Quadripartite Joint Secretariat on AMR underscored the urgency.
“AMR is among the top global health threats and disproportionately impacts the Global South. Abuja presents a critical opportunity to translate global agreements into real-world outcomes”, he said.
The meeting builds on momentum from previous milestones, including the 2024 UN General Assembly High-Level Meeting and the Jeddah Ministerial Summit, with a renewed focus on accountability through the “Troika” mechanism that ensures continuity between global forums.
A major benchmark remains the global target to cut AMR-related deaths by 10% by 2030, compared to 4.9 million deaths recorded in 2019. Experts emphasize that progress is achievable through practical interventions such as improved hygiene, responsible drug use, and expanded access to diagnostics and essential medicines.
Economic arguments are also gaining traction. According to Dr Alakija, every dollar invested in combating AMR could generate up to eleven dollars in return, making it not only a health priority but a smart financial decision.
Global institutions—including the World Health Organization, FAO, UNEP, and WOAH are backing the Abuja summit, reinforcing its significance as a coordinated international effort.
Alongside policy discussions, media engagement is being amplified. The Global AMR Media Alliance has announced its 2026 awards, including special recognition for reporting on the Abuja meeting and for stories highlighting the lived experiences of AMR survivors.
As the world turns its attention to Abuja, expectations are high that the summit will deliver more than declarations, setting in motion tangible actions to curb antimicrobial resistance and safeguard the future of global health.